ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+12.92% - 44,934 M€
+18.71% - 35,761 M€
+9.15% - 28 M€
+5.66% - 33 M€
+14.32% - 33 M€
+5.37% - 37 M€
-0.33% - 49 M€
+13.29% - 66 M€
+9.73% - 67 M€
+9.76% - 75 M€
+4.66% - 80 M€
+13.74% - 122 M€
+1.96% - 293 M€
+11.11% - 27,154 M€
+17.69% - 750 M€
+14.63% - 507 M€
+4.09% - 165 M€
+18.21% - 148 M€
+39.28%9.51% 15 M€
+35.63%9.43% 429 M€
+28.21%9.05% 78 M€
+28.50%9.05% 1,079 M€
+29.09%8.88% 9,953 M€
+27.45%8.54% 81 M€
+22.39%4.47% 7 M€
+17.21%4.4% 28 M€
+38.66%4.33% 11 M€
+65.64%4.15% 58 M€
+57.31%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated